Characterization of fibrosis changes in chronic hepatitis C patients after virological cure: A systematic review with meta-analysis

Fibrosis Regression Explains Differences in Outcome in HIV-/HCV-Coinfected Patients with Cirrhosis After Sustained Virological Response

(2015) José Luis Casado et al.   DIGESTIVE DISEASES AND SCIENCES

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

(2015)   HEPATOLOGY

EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis

(2015)   JOURNAL OF HEPATOLOGY

EASL Recommendations on Treatment of Hepatitis C 2015

(2015)   JOURNAL OF HEPATOLOGY

Hepatitis C

(2015) Daniel P Webster et al.   LANCET

Evolution of noninvasive tests of liver fibrosis is associated with prognosis in patients with chronic hepatitis C

(2014) Julien Vergniol et al.   HEPATOLOGY

Cirrhosis regression in hepatitis C patients with sustained virological response after antiviral therapy: a meta-analysis

(2014) Ehsaan Akhtar et al.   LIVER INTERNATIONAL

Risk factors for liver-related mortality in chronic hepatitis C patients: A deceased case-living control study

(2014) Qing-Lei Zeng   WORLD JOURNAL OF GASTROENTEROLOGY

Brief Communication: The Relationship of Regression of Cirrhosis to Outcome in Chronic Hepatitis C

(2013) Vincent Mallet et al.   ANNALS OF INTERNAL MEDICINE

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C

(2013) Thierry Poynard et al.   JOURNAL OF HEPATOLOGY

The diagnostic accuracy of Fibroscan® for cirrhosis is influenced by liver morphometry in HCV patients with a sustained virological response

(2013) Roberta D’Ambrosio et al.   JOURNAL OF HEPATOLOGY

Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C

(2013) Fred Poordad et al.   NEW ENGLAND JOURNAL OF MEDICINE

A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis

(2012) Roberta D'Ambrosio et al.   HEPATOLOGY

APASL consensus statements and management algorithms for hepatitis C virus infection

(2012) Masao Omata et al.   Hepatology International

Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon

(2011) Adrian M. Di Bisceglie et al.   HEPATOLOGY

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

(2011) Ira M. Jacobson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis

(2010) G. T. EVERSON et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

(2010) Andreas Stang   EUROPEAN JOURNAL OF EPIDEMIOLOGY

Histologic outcomes in hepatitis C-infected patients with varying degrees of virologic response to interferon-based treatments

(2010) Paul J. Pockros et al.   HEPATOLOGY

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

(2010) David Moher et al.   International Journal of Surgery